LAUSR

Carbon Dot@MXene Nanozymes with Triple Enzyme‐Mimic Activities for Mild NIR‐II Photothermal‐Amplified Nanocatalytic Therapy

Sign Up to like & get
recommendations!
1 Published in 2022 at "Advanced Healthcare Materials"

DOI: 10.1002/adhm.202202154

Abstract: Nanozymes have shown promising potential in disease treatment owing to the advantages of low‐cost, facile fabrication, and high stability. However, the highly complex tumor microenvironment (TME) and inherent low catalytic activity severely restrict the clinical… read more here.

Keywords: triple enzyme; nir photothermal; enzyme mimic; nanocatalytic therapy ... See more keywords

Insight into Surface Electronic Effects on Pd Nanostructures as Efficient Electrocatalysts.

Sign Up to like & get
recommendations!
2 Published in 2023 at "Nano letters"

DOI: 10.1021/acs.nanolett.3c00056

Abstract: Although the unique properties of nanomaterials have endowed enzyme-mimic catalysts with broad applications, the development of catalysts still relies on trial-and-error strategies without predictive indicators. Surface electronic structures have rarely been studied in enzyme-mimic catalysts.… read more here.

Keywords: electronic structures; insight surface; enzyme mimic; surface ... See more keywords

Deuterohemin-Peptide Enzyme Mimic-Embedded Metal-Organic Frameworks through Biomimetic Mineralization with Efficient ATRP Catalytic Activity.

Sign Up to like & get
recommendations!
0 Published in 2017 at "ACS applied materials & interfaces"

DOI: 10.1021/acsami.7b09218

Abstract: An enzyme mimic harboring iron porphyrin (DhHP-6) embedded in zeolite imidazolate framework-8 (ZIF-8) was constructed through a biomimetic mineralization approach to obtain composite DhHP-6@ZIF-8. The composite was then used as a catalyst in the atom… read more here.

Keywords: enzyme mimic; peptide enzyme; dhhp; biomimetic mineralization ... See more keywords

Albumin-Based Zn (II)-Quercetin Enzyme Mimic Scavenging ROS for Protection against Cardiotoxicity Induced by Doxorubicin

Sign Up to like & get
recommendations!
1 Published in 2022 at "Pharmaceuticals"

DOI: 10.3390/ph15121524

Abstract: Doxorubicin (DOX) is a chemotherapeutic agent that can cause cardiotoxicity leading to progressive, chronic, life-threatening cardiomyopathy, called DOX-induced cardiomyopathy (DIC). DIC is a fatal cardiomyopathy with a worse prognosis compared to other cardiomyopathies and limits… read more here.

Keywords: enzyme mimic; quercetin enzyme; cardiotoxicity; albumin based ... See more keywords